Skip to main content

Table 1 Characteristics of patients receiving Propofol/remifentanil or Sevoflurane/remifentanil anesthesia

From: Perioperative incidence of airway obstructive and hypoxemic events in patients with confirmed or suspected sleep apnea - a prospective, randomized pilot study comparing propofol/remifentanil and sevoflurane/remifentanil anesthesia

 

Propofol/remifentanil anesthesia

Sevoflurane/remifentanil anesthesia

p - value

n

27

27

 

Sex (male/female), n

18/9

16/11

 

Age (years)

61.1 ± 13

59.5 ± 10

ns*

Body-Mass-Index (kg m− 2)

30.3 ± 7.2

33.1 ± 5.1

ns

Anesthesia duration (min)

85.3 ± 42

109.5 ± 42

ns

PACU§ opioid dose (morphine equivalent, mg)

9.5 ± 4.4

11.5 ± 6.4

ns

  1. Data are presented as numbers or means ± SD
  2. *ns not significant
  3. §PACU post operative care unit